Welcome to the linuxcrusade.com.
| Bioenvision Shareholder Says Bid 'Ill-Timed' (TheStreet.com) |
|
SCO Capital is 'dissatisfied' by Genzyme's $5.60-a-share offer. Read more: |
| < Prev | Next > |
|---|
